By activating GLP-1 receptors in the hypothalamus and brainstem, these analogs promote satiety, leading to reduced food intake and weight loss ( Studies as Network Meta-analysis and clinical trials have shown that GLP1-RA can achieve a statistically significant decrease in HbA1C compared to placebo, as well as a weight reduction ranging between 1.3 and 8.65 kg ( With regard to cardioprotection, several mechanisms have been proposed
These are not magic tricks
Assays were initiated by replacing growth medium with 650 l of low-buffered RPMI-1640 growth medium without sodium bicarbonate, HEPES, and containing only 1% FBS
The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are secreted by enteroendocrine cells and augment insulin secretion in response to food ingestion in a glucose-dependent manner
Like GLP-1, it is also administered as a weekly injection and is approved for type 2 diabetes management, with promising results in weight loss trials